Liver Cancer Clinical Trials in Florida

51 recruiting studies across 4 cities

Browse by City

Miami

All Trials in Florida

Phase

Trial	Phase	Sponsor	Dist.
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma	Phase 3	AstraZeneca	<1 mi
Intravital Microscopy in Human Solid Tumors	N/A	Mayo Clinic	<1 mi
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas	Phase 2	Mayo Clinic	<1 mi
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor	Phase 1	Abbisko Therapeutics Co, Ltd	<1 mi
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program	Phase 2	Mayo Clinic	<1 mi
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)	Phase 1/2	GI Innovation, Inc.	<1 mi
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors	Phase 1	Exelixis	<1 mi
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors	Phase 1/2	Mayo Clinic	<1 mi
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer	Phase 2	Mayo Clinic	<1 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	<1 mi
FOG-001 in Locally Advanced or Metastatic Solid Tumors	Phase 1/2	Parabilis Medicines, Inc.	<1 mi
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer	Phase 2	Academic and Community Cancer Research United	<1 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma	Phase 1	Alnylam Pharmaceuticals	<1 mi
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform	—	Mayo Clinic	<1 mi
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer	Phase 1	TORL Biotherapeutics, LLC	<1 mi
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma	Phase 1	Shanghai Henlius Biotech	<1 mi
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC	Phase 1/2	RayzeBio, Inc.	<1 mi
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)	N/A	Johns Hopkins University	<1 mi
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	<1 mi
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment	Phase 1	Incyte Corporation	<1 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI	N/A	VA Office of Research and Development	<1 mi
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC	Phase 2	Replimune, Inc.	<1 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors	Phase 2	SWOG Cancer Research Network	<1 mi
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen	Phase 3	Crinetics Pharmaceuticals Inc.	<1 mi
Observational Study Protocol: LIVER-R	—	AstraZeneca	<1 mi
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.	Phase 1/2	Pfizer	<1 mi
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma	Phase 1/2	Tvardi Therapeutics, Incorporated	<1 mi
Multi-analyte Blood Test Clinical Trial	—	Helio Genomics	<1 mi
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease	Phase 2	Delcath Systems Inc.	<1 mi
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening	N/A	H. Lee Moffitt Cancer Center and Research Institute	<1 mi
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC	Phase 2	H. Lee Moffitt Cancer Center and Research Institute	<1 mi
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease	Phase 2	Delcath Systems Inc.	<1 mi
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT	—	The Radiosurgery Society	<1 mi
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)	—	HistoSonics, Inc.	<1 mi
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations	Phase 2	Fore Biotherapeutics	<1 mi
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors	Phase 1/2	ModeX Therapeutics, An OPKO Health Company	<1 mi
Targeted Navigation in Hepatocellular Carcinoma (HCC)	N/A	University of Miami	<1 mi
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma	Phase 2	University of Miami	<1 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors	Phase 1/2	Tango Therapeutics, Inc.	<1 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	<1 mi
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)	Phase 2	Memorial Sloan Kettering Cancer Center	<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	<1 mi
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial	Phase 3	ECOG-ACRIN Cancer Research Group	<1 mi
CapTemY90 for Grade 2/3 NET Liver Metastases	Phase 2	Abramson Cancer Center at Penn Medicine	<1 mi
PSMA PET for the Staging and Management of Hepatocellular Carcinoma	—	VA Office of Research and Development	<1 mi
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy	Phase 1/2	7 Hills Pharma, LLC	16 mi
DESTINY-PANTUMOUR04	—	AstraZeneca	18 mi
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors	Phase 2	DualityBio Inc.	28 mi
Integrated Cancer Repository for Cancer Research	—	University of Nebraska	29 mi
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors	Phase 1	Angiex, Inc.	43 mi
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400	Phase 1	AbbVie	43 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.